Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Historical Holders from Q3 2024 to Q3 2025

Symbol
CVKD on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
1.78M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
114K
Holdings value
$1.57M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
17
Number of buys
8
Number of sells
-5
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pham Quang X 23.6% $7.12M 421K Quang X. Pham 23 Jan 2025
Havlickova 648 a.s. 4.39% $1.32M 78.3K Havlickova 648 a.s. 31 Dec 2024
MURPHY JOHN RAYMOND 2.96% $899K 53.2K John Raymond Murphy 31 Dec 2024

Institutional Holders of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 114K $1.57M +$636K $13.83 17
2025 Q2 68.3K $823K -$12.4K $12.05 14
2025 Q1 69.3K $1.22M +$962K $17.63 13
2024 Q4 14.8K $215K +$214K $14.49 9
2024 Q3 5 $68.00 +$68.00 $13.60 1